Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Global Oncology Diagnostics in IVD Growth Opportunities
... expected to witness significant growth, driven by an increase in cancer incidence, technological developments in diagnostic tests, the growing number of screening tests, and supportive government initiatives. Owing to the intense competition in the market, ... Read More
-
Global Vulvar Cancer Market - 2023-2030
... vulvar cancer market is expected to exhibit a CAGR of 5.9% during the forecast period (2023-2030). The ongoing research and development efforts for novel drugs are driving up demand for vulvar cancer market trends. The ... Read More
-
Global Cancer Biomarkers Market - 2023-2030
... cancer biomarker market is expected to exhibit a CAGR 12.3% during the forecast period (2023-2030). The emergence of liquid biopsy, use of genomic biomarkers, immuno-oncology biomarkers, and integration of artificial intelligence (AI) are driving up ... Read More
-
Cancer Biomarkers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... global cancer biomarkers market is poised for significant growth and expansion in the upcoming years. Cancer biomarkers play a crucial role in early detection, diagnosis, and cancer monitoring applications by indicating the presence of cancer ... Read More
-
Antibacterial Haemostatic Gels Market Share, Size, Trends, Industry Analysis Report, By Product Type (Urinanalysis Testing Kits, Hematology Testing Kits, Blood Pressure Monitoring Devices, Blood Glucose Monitoring Devices, and Others); By End User; By Reg
... Forecast, 2023-2032 The global antibacterial haemostatic gels market size is expected to reach USD 2,452.94 million by 2032, according to a new study by Polaris Market Research. The report “Antibacterial Haemostatic Gels Market Share, Size, ... Read More
-
Humanized Mouse and Rat Model Market by Type (Genetic Models, Cell-based Models (CD34, BLT, PMC), Rat Models), Application (Oncology, Immunology, Neuroscience, Toxicology, Infectious Diseases), End User (Pharma, Biotech) & Region - Global Forecast to 2028
... The global humanized mouse and rat model market is projected to reach USD 349 million by 2028 from USD 259 million in 2023, at a CAGR of 6.2% during the forecast period of 2023 to ... Read More
-
Global Cell Freezing Media Market Size study & Forecast, by Product (DMSO, Glycerol) by Application (Stem Cell lines, Cancer Cell Lines, Others), by End Use (Pharmaceutical and Biotechnological Companies, Research & Academic Institutes, Others), and Regional Analysis, 2023-2030
... Regional Analysis, 2023-2030 Global Cell Freezing Media Market is valued approximately at USD 140.1 million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.62% over the forecast period ... Read More
-
2023 France Hematology and Flow Cytometry Market: 2022 Analyzer and Consumable Supplier Shares, 2022-2027 Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... current suppliers and potential market entrants identify and evaluate business opportunities emerging in German hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the German hematology ... Read More
-
2023 Europe Hematology and Flow Cytometry Market: France, Germany, Italy, Spain, UK - 2022 Analyzer and Consumable Supplier Shares, 2022-2027 Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Instrumentation, Opportunities for Suppliers
... This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in French hematology and flow cytometry markets during the next five years.; The report explores business ... Read More
-
Microcatheters Market by Type (Delivery, Diagnostic, Aspiration, Steerable), Design (Single, Dual), Application (Cardiovascular, Neurovascular, Peripheral Vascular, Oncology), End-User (Hospitals, Ambulatory Surgical Centers) - Global Forecast to 2028
... USD 1,142 million by 2028 from USD 874 million in 2023, growing at a CAGR of 5.5% during the forecast period. The rise in advantages offered by microcatheter like Minimally Invasive, precise navigation, and targeted ... Read More
-
Global Hodgkin’s Lymphoma Market - 2023-2030
... Hodgkin’s lymphoma market is expected to exhibit a CAGR of 9.8% during the forecast period (2023-2030). The increasing technological advancements and the growing investments in novel products are driving up demand for Hodgkin’s lymphoma market ... Read More
-
Global Non-Hodgkin Lymphoma Market - 2023-2030
... non-Hodgkin lymphoma market is expected to exhibit a CAGR of 8.2% during the forecast period (2023-2030). The NHL market has witnessed a notable emphasis on the development and commercialization of targeted therapies. Biomarker identification and ... Read More
-
Global Breast Cancer Drugs Market Market - 2023-2030
... 2030. The Global Breast Cancer Drugs Market is expected to exhibit a CAGR of 9.2% during the forecast period 2023-2030. The increasing demand for discovering novel therapies and optimizing existing treatments are driving up demand ... Read More
-
Global Bone Cancer Market - 2023-2030
... Bone Cancer Market is expected to exhibit a CAGR of 4.8% during the forecast period 2023-2030. Bone cancer can begin in any bone in the body, but it most commonly affects the pelvis or the ... Read More
-
Pharmacogenomics Market by Technology (Sequencing, Polymerase Chain Reaction, Gel Electrophoresis, Mass Spectrometry, Microarray, and Others), Application (Cardiovascular Diseases, Infectious Diseases, Oncology, Neurological Diseases, Psychiatry, Pain Management, and Others), and End User (Hospitals & Clinics, Research Institutions and Academic Institutes and Others): Analysis and Industry Forecast, 2027
... Institutions and Academic Institutes and Others): Analysis and Industry Forecast, 2027 The pharmacogenomics market refers to the market for diagnostic tests and technologies used to study an individual's genetic makeup and how it affects their ... Read More
-
Myelofibrosis Treatment Market by Type (Targeted therapy, Chemotherapy and Others), Distribution Channel (Hospital pharmacies, Retail and specialty pharmacies and Online pharmacies) and Geography (North America, Europe, APAC and RoW)-Forecast up to 2027
... unusual type of blood cancer. The bone marrow becomes scarred, which makes it complicated to make blood cells. It belongs to a group of diseases referred as myeloproliferative disorders or myeloproliferative neoplasms. Stem cells are ... Read More
-
Natural Killer Cells Therapeutics Market by Therapeutics (NK Cell Therapies and NK Cell Directed Antibodies), Application (Cancer, Gastrointestinal Diseases, Immunoproliferative Disorders, and Others), and End User (Research Centers & Institutes, Hospitals, and Others): Global Opportunity Analysis and Industry Forecast, 2027
... Analysis and Industry Forecast, 2027 The Natural Killer (NK) Cells Therapeutics market refers to the pharmaceutical products and therapies aimed at utilizing and enhancing the functions of natural killer cells for therapeutic purposes. Natural killer ... Read More
-
Non-Small Cell Lung Cancer Market by Type (Squamous Cell Carcinoma, Large Cell Carcinoma, Others and Adenocarcinoma), Treatment Type (Chemotherapy, Targeted Therapy and Immunotherapy), Distribution Channel (Hospital Pharmacy, Drug Store and Retail Pharmacy and Online Pharmacy) and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027
... and Geography (North America, Europe, APAC and RoW) - Forecast up to 2027 Non-small cell lung cancer is a form of lung cancer, where malignant tumor cells are formed in the lungs. It comprises of ... Read More
-
Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... reach US$ 14.7 Billion by 2028, exhibiting a growth rate (CAGR) of 21.6% during 2023-2028. Cancer is a lifestyle disease that occurs due to the abnormal growth of cells and may result in the formation ... Read More
-
Bronopol Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
... US$ 1.5 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028. Bronopol is a colorless, water-soluble organic compound, produced by the bromination of di(hydroxymethyl)-nitromethane. It is supplied as crystals or crystalline powder, ... Read More
-
Europe Breast Cancer Screening Market, Size, Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis
... Breast cancer is the leading form of cancer affecting women in Europe, with approximately 400,000 new cases annually and resulting in 100,000 fatalities. This type of cancer originates from malignant tumors that develop in breast ... Read More
-
Medullary Thyroid Cancer
... in the C cells of the thyroid gland. Unlike other types of thyroid cancer that arise from follicular cells, MTC is associated with the overgrowth of these C cells and the production of elevated levels ... Read More
-
Biliary Tract Cancers (BTCs)
... various factors, including the increasing prevalence and incidence of BTCs, advancements in diagnostic technologies, evolving treatment approaches, growing awareness and screening programs, collaborative research efforts, favorable reimbursement policies, and the growing geriatric population. Despite the ... Read More
-
2023 Global Forecast for Pet Cancer Therapeutics Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Cutaneous T-Cell Lymphoma (CTCL)- Pipeline Insight, 2023
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
Research Assistance
